Literature DB >> 23212020

Bioserotypes and virulence markers of Yersinia enterocolitica strains isolated from mallards (Anas platyrhynchos) and Pheasants (Phasianus colchicus).

Agata Bancerz-Kisiel1, Anna Szczerba-Turek, Karolina Lipczyńska, Tomasz Stenzel, Wojciech Szweda.   

Abstract

Yersinia enterocolitica is the causative agent of yersiniosis in different animal species and in humans. Food contaminated with Y. enterocolitica is the main source of infection for humans, and swine plays a major role in the transmission of the disease. There are a limited number of reports of the prevalence of Y. enterocolitica in wild animals and birds. This study characterized virulence markers associated with Y. enterocolitica isolates recovered from mallards and pheasants. Y. enterocolitica strains were isolated from 5 (11.11%) of 45 mallards originating from a cold culture (peptone, sorbitol, and bile salts medium) belonging to biotype 1A. Serotyping showed that three of these five serotypes represented serotype O:8, one belonged to serotype O:5, and one did not agglutinate with any of the sera and was classified as nonidentified. Molecular analysis for virulence markers detected the ystB gene, which encodes an enterotoxin, in five isolates. Y. enterocolitica was not detected in any of the 16 examined pheasants.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23212020     DOI: 10.4315/0362-028X.JFP-12-214

Source DB:  PubMed          Journal:  J Food Prot        ISSN: 0362-028X            Impact factor:   2.077


  2 in total

1.  The first pathogenic Yersinia enterocolitica bioserotype 4/O:3 strain isolated from a hunted wild boar (Sus scrofa) in Poland.

Authors:  A Bancerz-Kisiel; A Platt-Samoraj; A Szczerba-Turek; K Syczyło; W Szweda
Journal:  Epidemiol Infect       Date:  2015-01-22       Impact factor: 4.434

2.  Bioserotypes, Virulence Markers, and Antimicrobial Susceptibility of Yersinia enterocolitica Strains Isolated from Free-Living Birds.

Authors:  Marta Odyniec; Tomasz Stenzel; Dorota Ławreszuk; Agata Bancerz-Kisiel
Journal:  Biomed Res Int       Date:  2020-03-17       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.